Hsu YC - Search Results

1

Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.

Liou JM, Fang YJ, Chen CC, Bair MJ, Chang CY, Lee YC, Chen MJ, Chen CC, Tseng CH, Hsu YC, Lee JY, Yang TH, Luo JC, Chang CC, Chen CY, Chen PY, Shun CT, Hsu WF, Hu WH, Chen YN, Sheu BS, Lin JT, Wu JY, El-Omar EM, Wu MS; Taiwan Gastrointestinal Disease and Helicobacter Consortium. Liou JM, et al. Among authors: hsu yc, hsu wf. Lancet. 2016 Nov 12;388(10058):2355-2365. doi: 10.1016/S0140-6736(16)31409-X. Epub 2016 Oct 18. Lancet. 2016. PMID: 27769562 Clinical Trial.

2

Psychopathology and personality trait in subgroups of functional dyspepsia based on Rome III criteria.

Hsu YC, Liou JM, Liao SC, Yang TH, Wu HT, Hsu WL, Lin HJ, Wang HP, Wu MS. Hsu YC, et al. Among authors: hsu wl. Am J Gastroenterol. 2009 Oct;104(10):2534-42. doi: 10.1038/ajg.2009.328. Epub 2009 Jun 16. Am J Gastroenterol. 2009. PMID: 19532128

3

Delayed endoscopy as a risk factor for in-hospital mortality in cirrhotic patients with acute variceal hemorrhage.

Hsu YC, Chung CS, Tseng CH, Lin TL, Liou JM, Wu MS, Hu FC, Wang HP. Hsu YC, et al. J Gastroenterol Hepatol. 2009 Jul;24(7):1294-9. doi: 10.1111/j.1440-1746.2009.05903.x. J Gastroenterol Hepatol. 2009. PMID: 19682197

4

Endoscopy timing in acute variceal hemorrhage: perhaps not the sooner the better, but delay not justified.

Hsu YC, Chen CC, Wang HP. Hsu YC, et al. Am J Gastroenterol. 2009 Oct;104(10):2629-30; author reply 2630-1. doi: 10.1038/ajg.2009.432. Am J Gastroenterol. 2009. PMID: 19806094 No abstract available.

5

Early risk stratification with simple clinical parameters for cirrhotic patients with acute upper gastrointestinal bleeding.

Hsu YC, Liou JM, Chung CS, Tseng CH, Lin TL, Chen CC, Wu MS, Wang HP. Hsu YC, et al. Am J Emerg Med. 2010 Oct;28(8):884-90. doi: 10.1016/j.ajem.2009.04.037. Epub 2010 Mar 26. Am J Emerg Med. 2010. PMID: 20887910

6

Proton pump inhibitor versus prokinetic therapy in patients with functional dyspepsia: is therapeutic response predicted by Rome III subgroups?

Hsu YC, Liou JM, Yang TH, Hsu WL, Lin HJ, Wu HT, Lin JT, Wang HP, Wu MS. Hsu YC, et al. Among authors: hsu wl. J Gastroenterol. 2011 Feb;46(2):183-90. doi: 10.1007/s00535-010-0334-1. Epub 2010 Oct 19. J Gastroenterol. 2011. PMID: 20957498 Clinical Trial.

7

Can clinical features stratify use of endoscopy for dyspeptic patients with high background prevalence of upper gastrointestinal cancer?

Hsu YC, Yang TH, Liou JM, Hsu WL, Lin HJ, Wu HT, Lin JT, Wang HP, Wu MS. Hsu YC, et al. Among authors: hsu wl. Dig Liver Dis. 2012 Mar;44(3):218-23. doi: 10.1016/j.dld.2011.10.012. Epub 2011 Nov 23. Dig Liver Dis. 2012. PMID: 22115792

8

Glycated hemoglobin A1c is superior to fasting plasma glucose as an independent risk factor for colorectal neoplasia.

Hsu YC, Chiu HM, Liou JM, Chang CC, Lin JT, Liu HH, Wu MS. Hsu YC, et al. Cancer Causes Control. 2012 Feb;23(2):321-8. doi: 10.1007/s10552-011-9880-y. Epub 2011 Nov 29. Cancer Causes Control. 2012. PMID: 22124615

9

Entecavir versus lamivudine in the treatment of chronic hepatitis B patients with hepatic decompensation.

Hsu YC, Mo LR, Chang CY, Perng DS, Tseng CH, Lo GH, Tai CM, Lin CW, Hsu CC, Hsu CY, Huang SC, Lin JT. Hsu YC, et al. Among authors: hsu cc, hsu cy. Antivir Ther. 2012;17(4):605-12. doi: 10.3851/IMP2027. Epub 2011 Dec 20. Antivir Ther. 2012. PMID: 22301517

10

Long-term risk of recurrent peptic ulcer bleeding in patients with liver cirrhosis: a 10-year nationwide cohort study.

Hsu YC, Lin JT, Chen TT, Wu MS, Wu CY. Hsu YC, et al. Hepatology. 2012 Aug;56(2):698-705. doi: 10.1002/hep.25684. Epub 2012 Jul 6. Hepatology. 2012. PMID: 22378148

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,447 results

Search Page